文献速递头颈外科咽喉与嗓音

局部晚期T3/T4a期喉癌原发全喉切除术与器官保留治疗的比较

Primary Total Laryngectomy versus Organ Preservation for Locally Advanced T3/T4a Laryngeal Cancer.
PubMed 文献 · Laryngoscope · 2022-06-26

全喉切除术与器官保留治疗的总生存相似;T3期器官保留治疗的无病生存更差,局部复发率28.9%对7.1%(p<0.01);全喉切除术患者正常饮食比例更高(75.4%对53.8%,p<0.001)。

要点

  • T3期患者接受器官保留治疗的局部复发率28.9%,高于全喉切除术的7.1%(p<0.01)。
  • T4期患者两种治疗的总生存无差异,可能与严格的患者选择有关。
  • 全喉切除术患者正常饮食比例75.4%,高于器官保留治疗的53.8%(p<0.001)。

核心结论

  • T4期患者两种治疗的总生存无差异,可能与严格的患者选择有关。
  • T3期接受器官保留治疗的患者无病生存更差,可能因局部复发率高。
  • 约40%的局部复发患者不适合行挽救性喉切除术。
  • 全喉切除术患者的吞咽和言语结局与器官保留治疗患者相当。

研究设计与样本

  • 回顾性队列研究,单中心三级医疗机构。
  • 纳入2000年1月1日至2018年12月31日接受原发全喉切除术或器官保留治疗的喉癌患者。
  • 共118例接受原发全喉切除术,119例接受器官保留治疗。
  • 证据等级:3。

主要发现

  • 全喉切除术与器官保留治疗的总生存相似。
  • 按T分期分层,T3期接受器官保留治疗的患者无病生存较全喉切除术更差。
  • T3期患者中,器官保留治疗组28例(28.9%)出现局部复发,全喉切除术组3例(7.1%)(p<0.01)。
  • 共20例器官保留治疗组局部复发患者接受挽救性手术,其总生存与初始全喉切除术患者相似;约14例器官保留治疗组局部复发患者未接受挽救性手术。
  • 全喉切除术组89例(75.4%)达到正常饮食,器官保留治疗组64例(53.8%)(p<0.001)。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Organ preservation (OP) treatment for advanced laryngeal cancer has increased compared to primary total laryngectomy. Our study compares oncologic and functional outcomes between these approaches. STUDY DESIGN: Retrospective cohort study. SETTING: Single tertiary care institution. METHODS: Retrospective review of patients receiving primary total laryngectomy or OP for laryngeal cancer between 1/1/2000 and 12/31/2018. RESULTS: A total of 118 patients received primary total laryngectomy and 119 received OP. Overall survival was similar between total laryngectomy and OP. When stratified by T stage, disease-free survival was worse among T3 patients receiving OP versus total laryngectomy. In T3 patients, 28 OP patients experienced local recurrence (28.9%) compared to 3 total laryngectomy patients (7.1%; p < 0.01). In total, 20 OP patients with local recurrence received salvage surgery. These patients had similar overall survival to patients who underwent initial total laryngectomy (TL). About 14 OP patients with local recurrence did not receive salvage surgery. About 89 (75.4%) TL patients achieved normal diet as compared to 64 (53.8%) OP patients (p < 0.001). In TL patients, 106 (89.8%) received primary or secondary tracheoesophageal-prosthesis, 82 (77.4%) of whom achieved completely understandable speech. CONCLUSIONS: There was no difference in survival by treatment in T4 patients, possibly because of strict patient selection. However, disease-free survival was worse in T3 patients receiving OP, likely due to a high local recurrence rate. Approximately 40% of patients with local recurrence were not eligible for salvage laryngectomy. TL patients had comparable swallowing and speech outcomes with OP patients. LEVEL OF EVIDENCE: 3 Laryngoscope, 133:1122-1131, 2023.

来源:Laryngoscope,查看原文。版权归原作者所有。

引用

  1. Lee MY, Belfiglio M, Zeng J, et al. Primary Total Laryngectomy versus Organ Preservation for Locally Advanced T3/T4a Laryngeal Cancer. Laryngoscope. 2022. PMID: 35754153. doi:10.1002/lary.30254

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。